Selective immunoglobulin A deficiency

Last updated: December 18, 2025

Selective immunoglobulin A deficiency

Watch later

Watch later

Escherichia coli
Mycobacterium tuberculosis (Tuberculosis)
Mycoplasma pneumoniae
Varicella zoster virus
Herpes simplex virus
Influenza virus
Norovirus
HIV (AIDS)
Miscellaneous cell wall synthesis inhibitors
Complement system
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
VDJ rearrangement
Somatic hypermutation and affinity maturation
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Abscesses
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
DiGeorge syndrome
Hyper IgM syndrome
Leukocyte adhesion deficiency
Complement deficiency
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Hemophilia
Von Willebrand disease
Disseminated intravascular coagulation
Protein C deficiency
Antiphospholipid syndrome
Protein S deficiency
Factor V Leiden
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Neisseria gonorrhoeae
Haemophilus influenzae
Chlamydia pneumoniae
Viral structure and functions
Candida
Mechanisms of antibiotic resistance
Neuraminidase inhibitors
Neisseria meningitidis
Mycobacterium avium complex (NORD)
Chlamydia trachomatis
Treponema pallidum (Syphilis)
Human herpesvirus 8 (Kaposi sarcoma)
Epstein-Barr virus (Infectious mononucleosis)
Antituberculosis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Herpesvirus medications
Nucleoside reverse transcriptase inhibitors (NRTIs)
Vaccinations
Autoimmune hemolytic anemia
Anemia of chronic disease
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Aortic dissections and aneurysms: Pathology review
Hypertension: Pathology review
Obstructive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Restrictive lung diseases: Pathology review

Transcript

Watch video only

Selective immunoglobulin A deficiency is a condition where there’s a lack of immunoglobulin or antibody A, called IgA for short. It’s called “selective” because all the other antibody classes, IgM, IgG, IgE and IgD are produced normally. IgA is in charge of protecting the mucosal surfaces of the body against foreign invaders, so without it, there’s a higher risk of mucosal infections.

Now, B cells make antibodies, and normally, B cells are “born” in the bone marrow, which is the spongy tissue inside some bones of the body. This is where they develop their B cell receptors on their surface which eventually can get released - and when they’re freely floating in the blood they’re called antibodies.

Antibodies are Y- shaped protein molecules, formed by two heavy and two light chains, each of which has a variable region, at one end, and a constant region (C region) at the other end. Variable regions are unique to each B cell and they are designed to bind to a very specific antigen, whereas C regions determine the antibody class.

Initially all of the B cells have IgM and IgD class antibodies on their surface, with each B cell recognizing and binding to its own unique antigen. Mature B cells leave the bone marrow and migrate to peripheral lymphoid organs, like the spleen, lymph nodes or mucosa-associated lymphoid tissue, which is also called MALT.

MALT is composed of clusters of lymphoid tissue scattered under the mucous membranes lining the mouth, airways, and digestive tract. This is a really strategic position, because a variety of antigens are constantly being picked up and filtered from these body tissues. As a result, B cells are likely to encounter an antigen they recognize. A bit like spending time at a train station during rush hour to look for someone that catches your eye.

If two of a B cell’s receptors bind to the same antigen, they can cross-link - meaning that two adjacent receptors on the B cell surface can get pulled close together. When that happens the B cell will often take in the antigen, digest it, and present pieces of it on another cell surface protein called a major histocompatibility class II molecule, or MHC class II.

If a nearby T cell receptor recognizes this antigen bound to an MHC class II molecule, the T cell releases cytokines that make the B cell differentiate into a plasma cell, which is a cell that makes lots of antibodies.

The specific set of cytokines received by the B cell determine how it class-switches, meaning whether it switches from making IgM and IgD to making IgG, IgE or IgA. In class switching, what changes is only the constant region, and not the variable region of the antibody, meaning that the antigen specificity remains the same.

IgA is primarily produced when B cells are stimulated by interleukin- 5 (IL-5) or transforming growth factor- β or TGF- β. Class switching to IgA usually happens in mucosa-associated lymphoid tissue, or MALT, from where IgA is secreted into the saliva, sweat, or intestinal juices.

When IgA is secreted, it’s called secretory IgA, and it’s a dimer, meaning that two IgA molecules are joined together by a joining chain or J chain. This J chain is recognized by a poly-Ig receptor on the basolateral side of the mucous membrane, which helps it move across the epithelial cells and into the lumen.

Key Takeaways

Selective IgA deficiency is a common cause of immunodeficiency caused by low amounts of immunoglobulin A (IgA), resulting in low protection against infections of the mucous membranes lining the respiratory and gastrointestinal tracts. It is typically accompanied by normal levels of IgM, IgD, and IgG, and slightly elevated levels of IgE. Affected people are susceptible to infections of the mucous membranes lining the mouth, airways, and digestive tract.

Selective IgA deficiency often results from a failure of B cells to differentiate into IgA-secreting plasma cells, so IgA remains bound to their surface, along with IgM and IgD. Most people with selective IgA deficiency generally appear healthy, with no major symptoms. Sometimes, however, they may have more chronic infections, an increased frequency of atopy and asthma, as well as autoimmune diseases like rheumatoid arthritis. Selective IgA deficiency is associated with an increased risk of some malignancies, like gastric and colon cancer.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Practice parameter for the diagnosis and management of primary immunodeficiency" Annals of Allergy, Asthma & Immunology (2005)
  7. "Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)" Clinical and Experimental Immunology (2000)
  8. "Update on the use of immunoglobulin in human disease: A review of evidence" Journal of Allergy and Clinical Immunology (2017)
  9. "Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data" Journal of Allergy and Clinical Immunology (2017)